YM BioSciences Inc

YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF™, a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain.

Contact Details: 5045 Orbitor Drive Building 11, Suite 400 Mississauga Ontario L4W 4Y4 Canada Tel: 905.629.9761 Fax: 905.629.4959 Email: ir@ymbiosciences.com WWW: www.ymbiosciences.com

Loading...

Press Releases on YM BioSciences Inc:
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING	18th November, 2009	YM BioSciences Inc.	MISSISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
YM BIOSCIENCES REPORTS CYT997 ORAL VASCULAR DISRUPTING AGENT RESULTS PRESENTED AT AACR-NCI-EORTC MEETING	17th November, 2009	YM BioSciences Inc.	MISSISSAUGA, ON, Nov. 17 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS	11th November, 2009	YM BioSciences Inc.	MISSISSAUGA, ON, Nov. 11 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009	2nd November, 2009	YM BioSciences Inc.	- Follow-On Results from a Randomized Phase IIb Head & Neck Trial Demonstrate Efficacy of Nimotuzumab Without Severe, Class-Associated Toxicities - MISSISSAUGA, ON, Nov. 2
YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG	29th October, 2009	YM BioSciences Inc.	MISSISSAUGA, ON, Oct. 29 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of

BioNews Results for YM BioSciences Inc:
YM BioSciences Reports Fiscal First Quarter 2010 Operational and Financial Results	Pharma Live:  Nov 13 2009 3:50AM Matching: ym biosciences inc
Ym Biosciences Reports Fiscal First Quarter 2010 Operational And Financial Results	Genetic Engineering News:  Nov 12 2009 11:19AM Matching: ym biosciences inc
Ym Biosciences Reports Fiscal First Quarter 2010 Operational And Financial Results	KSLA:  Nov 12 2009 6:04AM Matching: ym biosciences inc
Ym Biosciences Reports Fiscal First Quarter 2010 Operational And Financial Results	KOTA Territory News:  Nov 12 2009 11:34AM Matching: ym biosciences inc
Ym Biosciences Reports Fiscal First Quarter 2010 Operational And Financial Results	Houston Business Journal:  Nov 11 2009 11:55PM Matching: ym biosciences inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more YM BioSciences Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 467 times since April 2007, the link to the organisation's website has been followed 65 times

Recent Search Terms used to find this page: YM BioSciences Inc TSX YM | ymi mississauga | ym biosciences | YM BioSciences Inc. products | YM BioSciences Inc. NYSE Amex YMI TSX YM | YM Biosciences email | ym biosciences inc | ym biosciences inc | ym biosciences | YM bioscience news | .

Search for more companies in Mississauga

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for YM BioSciences Inc